Using the Morris water maze to assess spatial learning and memory in weanling mice
Results showed improvements in glycemic status among pre-diabetic participants, further suggest potential metabolic benefits beyond weight reduction
Its a GLP-1 receptor agonist, a medication that mimics the incretin hormones in the body, which lowers blood sugar levels and has effects on appetite regulation
10.1186/s42269-023-01012-1 5 Abou-SeifH
Patients typically begin to see weight loss results within a few weeks of starting treatment with either Ozempic or Wegovy, with more significant and sustained weight reduction observed over several months (e.g., 68 weeks in clinical trials for Wegovy)
And weight loss from the medications, while impressive, wont, on its own, make heavy people thin